Top 10 Companies in the (R)-1,2-Butylene Oxide Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

Global (R)-1,2-Butylene oxide market size was valued at USD 78.4 million in 2025. The market is projected to grow from USD 82.6 million in 2026 to USD 134.2 million by 2034, exhibiting a CAGR of 6.3% during the forecast period.

(R)-1,2-Butylene oxide, also known as (R)-1,2-epoxybutane, is a chiral epoxide compound with the molecular formula C4H8O. It is a colorless, volatile liquid widely recognized for its high reactivity and stereochemical specificity, making it a valuable building block in asymmetric synthesis and fine chemical manufacturing. The compound finds application across pharmaceuticals, agrochemicals, and specialty chemical industries, where enantiomeric purity is critical to end‑product performance and regulatory compliance.

The market is gaining momentum driven by rising demand for enantiopure intermediates in pharmaceutical synthesis and the expanding role of chiral chemistry in drug development. Furthermore, growing investments in green chemistry and catalytic asymmetric processes are broadening the compound’s industrial applicability. BASF SE, Thermo Fisher Scientific, and TCI Chemicals are among the prominent suppliers actively catering to global demand for high‑purity (R)-1,2-Butylene oxide.

(R)-1,2-Butylene oxide Market – View in Detailed Research Report

Top 10 Companies in the (R)-1,2-Butylene Oxide Market

1️⃣ BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Pharmaceutical‑grade (R)-1,2‑Butylene oxide, advanced chiral catalysts, and specialty epoxide solutions

BASF leverages its extensive chiral chemistry portfolio to supply high‑purity epoxides to pharmaceutical and fine‑chemical sectors. The company’s integrated manufacturing network ensures consistent quality and rapid delivery, supporting clients in complex drug synthesis and specialty polymer production.

Sustainability Initiatives:

• Investments in bio‑based feedstock conversion to reduce carbon footprint
• Implementation of closed‑loop waste management in epoxide plants
• Partnerships with academic institutions to develop greener epoxidation catalysts

2️⃣ Dow Inc.

Headquarters: Midland, United States
Key Offering: High‑purity (R)-1,2‑Butylene oxide, chiral auxiliaries, and polymer intermediates

Dow’s focus on precision chemical manufacturing positions it as a key supplier for pharmaceutical and specialty polymer markets. The firm’s robust R&D pipeline delivers scalable production routes that maintain strict enantiomeric excess standards.

Sustainability Initiatives:

• Adoption of renewable energy sources for production facilities
• Development of low‑energy epoxidation processes
• Collaboration with downstream partners to optimize supply chain emissions

3️⃣ LyondellBasell Industries N.V.

Headquarters: Rotterdam, Netherlands
Key Offering: Industrial‑grade (R)-1,2‑Butylene oxide, polymer precursors, and catalyst systems

LyondellBasell’s expertise in large‑scale petrochemical production supports its role in delivering cost‑effective epoxides to fine‑chemical and polymer segments. The company prioritizes process efficiencies to meet growing demand for enantiopure intermediates.

Sustainability Initiatives:

• Integration of hydrogen‑bonding catalysts to lower solvent use
• Strategic investments in carbon capture for upstream processes
• Lifecycle assessment programs for product offerings

4️⃣ Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Specialty epoxides, chiral intermediates, and advanced polymer building blocks

Evonik’s focus on high‑value specialty chemicals enables it to supply enantiomerically pure epoxides for pharmaceutical and agrochemical applications. The company’s strong quality management framework aligns with regulatory requirements across markets.

Sustainability Initiatives:

• Use of renewable feedstocks for epoxide synthesis
• Development of catalyst recycling programs
• Engagement in circular economy projects within the chemical sector

5️⃣ Sumitomo Chemical Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Pharmaceutical‑grade (R)-1,2‑Butylene oxide, chiral auxiliaries, and specialty intermediates

Sumitomo Chemical’s commitment to precision chemistry supports its supply of high‑purity epoxides to the pharmaceutical and fine‑chemical industries. The company invests heavily in catalyst development to enhance enantioselectivity and reduce waste.

Sustainability Initiatives:

• Implementation of energy‑efficient epoxidation reactors
• Partnerships with downstream manufacturers to co‑develop greener synthesis routes
• Commitment to zero‑hazardous‑waste targets by 2030

6️⃣ Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High‑purity (R)-1,2‑Butylene oxide, chiral catalysts, and polymer intermediates

Tokyo Chemical Industry focuses on delivering enantiomerically pure epoxides for pharmaceutical and specialty polymer markets. The company’s R&D pipeline emphasizes scalable, cost‑effective production while maintaining stringent purity standards.

Sustainability Initiatives:

• Deployment of catalytic epoxidation processes with reduced solvent use
• Investment in renewable energy for production facilities
• Collaboration with academia to explore biocatalytic alternatives

7️⃣ Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical‑grade (R)-1,2‑Butylene oxide, chiral auxiliaries, and advanced polymer precursors

Merck’s chemical division supplies high‑purity epoxides to the pharmaceutical sector, supporting complex drug synthesis and specialty polymer development. The firm’s integrated approach ensures traceability and compliance with global quality standards.

Sustainability Initiatives:

• Adoption of renewable feedstocks for epoxide production
• Implementation of process intensification to lower energy consumption
• Partnerships with downstream partners to achieve shared sustainability targets

8️⃣ Hairui Fine Chemicals Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Pharmaceutical‑grade (R)-1,2‑Butylene oxide, chiral intermediates, and specialty chemical solutions

Hairui Fine Chemicals focuses on cost‑effective production of enantiopure epoxides for the growing Chinese pharmaceutical market. The company’s investment in process optimization and biocatalysis has enabled it to meet stringent purity requirements at scale.

Sustainability Initiatives:

• Use of bio‑derived feedstocks for epoxide synthesis
• Implementation of waste‑reduction programs in manufacturing
• Collaboration with regional universities for catalyst development

9️⃣ Pharmablock Sciences Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade (R)-1,2‑Butylene oxide, chiral catalysts, and specialty intermediates

Pharmablock Sciences supplies high‑purity epoxides to the Chinese pharmaceutical sector, emphasizing rapid scale‑up and compliance with international quality standards. The firm’s focus on process innovation supports its competitive positioning.

Sustainability Initiatives:

• Adoption of energy‑efficient epoxidation technologies
• Implementation of closed‑loop water usage in production
• Engagement in regional sustainability forums to share best practices

🔟 Hunan Asun Pharmaceutical Co., Ltd.

Headquarters: Changsha, China
Key Offering: Pharmaceutical‑grade (R)-1,2‑Butylene oxide, chiral intermediates, and specialty chemical products

Hunan Asun focuses on delivering enantiomerically pure epoxides to the domestic pharmaceutical market, supporting the development of single‑enantiomer drugs. The company’s investment in advanced catalyst systems has enabled it to maintain high purity while scaling production.

Sustainability Initiatives:

• Integration of renewable energy into manufacturing operations
• Development of low‑waste epoxidation processes
• Collaboration with local universities to advance green chemistry research

Download FREE Sample Report

Get Full Report

Market Outlook

Over the next decade, the (R)-1,2‑Butylene oxide market will continue to be shaped by the need for high‑purity intermediates in pharmaceutical synthesis and the expansion of chiral chemistry across fine‑chemical and polymer sectors. Companies that invest in scalable, low‑energy production routes and maintain rigorous quality controls will likely capture the largest share of the growing demand.

Future Trends

• Biocatalytic production methods, driven by engineered enzymes, are expected to lower costs and reduce waste.
• Digital integration of manufacturing processes will enable real‑time quality monitoring and yield optimization.
• Increasing regulatory focus on single‑enantiomer drugs will sustain demand for enantiopure epoxides.
• Emerging markets in Asia‑Pacific and Latin America will offer new growth avenues as local pharmaceutical production expands.